Patient Experiences With Virtual Reality Mindfulness Skills Training
1 other identifier
interventional
29
1 country
1
Brief Summary
This study aims to assess acceptability and preliminary efficacy of an intervention being administered clinically, a virtual reality (VR) mindfulness program. It is hypothesized that patients will find VR mindfulness an acceptable intervention and that it will reduce symptoms of anxiety.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable anxiety
Started May 2022
Typical duration for not_applicable anxiety
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 2, 2022
CompletedFirst Posted
Study publicly available on registry
March 22, 2022
CompletedStudy Start
First participant enrolled
May 6, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 18, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 18, 2023
CompletedApril 23, 2024
April 1, 2024
1.3 years
March 2, 2022
April 22, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Change in composite score on Client Satisfaction Questionnaire-8 (CSQ-8; Attkisson & Zwick, 1982)
An 8-item, empirically validated measure of satisfaction with a clinical program. Scores therefore range from 8 to 32, with lower values indicating lower satisfaction and higher values indicating higher satisfaction.
Immediately after first intervention (use of VR) and at hospital discharge an average of 10 days later
Secondary Outcomes (3)
Mean change in Subject Units of Distress (SUDS) from pre- to post-VR
Immediately before and after each intervention (use of VR), up to two times per week for duration of hospital stay (average 10 days)
Mean change in Subjective units of relaxation from pre-to post-VR
Immediately before and after each intervention (use of VR), up to two times per week for duration of hospital stay (average 10 days)
Mean change in General Anxiety Disorder-7 (GAD-7; Spitzer et al., 2006) from baseline to discharge
Immediately before first intervention (use of VR) and at hospital discharge an average of 10 days later
Study Arms (1)
Patients using VR Mindfulness Program
OTHERParticipants are inpatients on any NYP/WCM unit that use VR mindfulness programs; any patient referred for a psychological or neuropsychological evaluation by their treatment team will have the opportunity to complete the VR program. The study is seeking to evaluate the feasibility and preliminary efficacy of the VR mindfulness intervention.
Interventions
The VR program combines immersive, 3D visuals and audio with mindfulness skills practice. The program is designed to train participants you to calm their bodied and minds and its use is designed to enhance mindfulness practice. VR is a platform that has been used for a variety of applications, including gaming, entertainment, education and training.
Eligibility Criteria
You may qualify if:
- Referred to psychology/neuropsychology
- Identified by treatment team for use of VR mindfulness intervention
- Able to provide informed consent or assent
- Patient is over the age of 18
You may not qualify if:
- Has not engaged in VR mindfulness intervention.
- Determination by clinical team that patient cannot or would not benefit from participation in VR.
- Reasons may include history of severe motion sickness or seizures, history of destruction of property, visual disturbance, vertigo, and cognitive impairment, delirium, and current or past diagnosis of a psychotic disorder
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Weill Cornell Medicine
New York, New York, 10065, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michelle Pelcovitz
Weill Cornell Psychiatry
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 2, 2022
First Posted
March 22, 2022
Study Start
May 6, 2022
Primary Completion
August 18, 2023
Study Completion
August 18, 2023
Last Updated
April 23, 2024
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will not share